APA

Rafati S., Kariminia A., Seyde-Eslami S., Narimani M., Taheri T. & Lebbatard M. (20021127). Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation. : Vaccine.

Chicago

Rafati Sima, Kariminia Amina, Seyde-Eslami Shiva, Narimani Manijeh, Taheri Tahere and Lebbatard Mai. 20021127. Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation. : Vaccine.

Harvard

Rafati S., Kariminia A., Seyde-Eslami S., Narimani M., Taheri T. and Lebbatard M. (20021127). Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation. : Vaccine.

MLA

Rafati Sima, Kariminia Amina, Seyde-Eslami Shiva, Narimani Manijeh, Taheri Tahere and Lebbatard Mai. Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation. : Vaccine. 20021127.